Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR)

36.23
Delayed Data
As of May 20
 +1.08 / +3.07%
Today’s Change
27.87
Today|||52-Week Range
93.66
-45.35%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$3.8B

Company Description

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by R. Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Contact Information

Arrowhead Pharmaceuticals, Inc.
177 East Colorado Boulevard
Pasadena California 91105
P:(626) 304-3400
Investor Relations:

Employees

Shareholders

Individual stakeholders6.78%
Mutual fund holders40.71%
Other institutional24.64%

Top Executives

Christopher Richard AnzalonePresident, Chief Executive Officer & Director
Kenneth Allen MyszkowskiChief Financial Officer
Javier San MartinChief Medical Officer
Jeff KetelhutVice President-Information Technology & Systems
Caroline LaPlaca DavisVice President-Clinical Operations